In breast cancer cells, Efp is demonstrated to act as an E3 ubiquitin ligase that targets cell cycle checkpoint protein 14-3-3σ for the proteasomal degradation, leading to the promotion of tumor formation in a mouse xenograft model [6]. The gene discussed is TRIM25; the disease is breast carcinoma.